A multicentric trial (Olympia-MITO 13) on the accuracy of laparoscopy to assess peritoneal spread in ovarian cancer

American Journal of Obstetrics and Gynecology

Volumn 209, Issue 5, 2013, Pages 462.e1-462.e11

  Fagotti, Anna ^a   Vizzielli, Giuseppe ^b   De Iaco, Pierandrea ^c   Surico, Daniela ^d   Buda, Alessandro ^e   Mandato, Vincenzo Dario ^f   Petruzzelli, Francesco ^g   Ghezzi, Fabio ^h   Garzarelli, Salvatore ⁱ   Mereu, Liliana ^j   Viganò, Riccardo ^k   Tateo, Saverio ^l   Fanfani, Francesco ^b   Scambia, Giovanni ^b  

^a UNIVERSITY OF PERUGIA   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^e SAN GERARDO HOSPITAL   (Italy)

^f S MARIA NUOVA HOSPITAL   (Italy)

^g CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^h UNIVERSITY OF INSUBRIA   (Italy)

ⁱ Dipartimento Interaziendale di Neuroscienze del Ponente Ligure   (Italy)

^j Oncologic Center of Florence   (Italy)

^k SAN RAFFAELE HOSPITAL   (Italy)

^l SANTA CHIARA HOSPITAL   (Italy)

more..

Author keywords

accuracy; carcinomatosis; laparoscopy; ovarian cancer; specificity

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; LAPAROSCOPY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OBSERVER VARIATION; OVARY CANCER; PERITONEUM CANCER; PRIORITY JOURNAL; RELIABILITY; SCORING SYSTEM;

EID: 84886798436     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2013.07.016     Document Type: Article

References (22)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics 2012 CA Cancer J Clin 62 2012 10 29
2. R.E. Bristow, R.S. Tomacruz, D.K. Armstrong, E.L. Trimble, and F.J. Montz Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis J Clin Oncol 20 2002 1248 1259
3. S.J. Chang, R.E. Bristow, and H.S. Ryu Impact of complete cytoreduction leaving no gross residual disease associated with radical cytoreductive surgical procedures on survival in advanced ovarian cancer Ann Surg Oncol 19 2012 4059 4067
4. A. Elattar, A. Bryant, B.A. Winter-Roach, M. Hatem, and R. Naik Optimal primary surgical treatment for advanced epithelial ovarian cancer Cochrane Database Syst Rev 2011 CD007565
5. S. Kang, and B.H. Nam Does neoadjuvant chemotherapy increase optimal cytoreduction rate in advanced ovarian cancer? Meta-analysis of 21 studies Ann Surg Oncol 16 2009 2315 2320
6. G. Ferrandina, G. Sallustio, and A. Fagotti Role of CT scan-based and clinical evaluation in the preoperative prediction of optimal cytoreduction in advanced ovarian cancer: a prospective trial Br J Cancer 101 2009 1066 1073
7. D.S. Chi, O. Zivanovic, and M.J. Palayekar A contemporary analysis of the ability of preoperative serum Ca-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinoma Gynecol Oncol 112 2009 6 10
8. A.E. Axtell, M.H. Lee, and R.E. Bristow Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer J Clin Oncol 25 2007 384 389
9. S.M. Eisenkop, R.L. Friedman, and H.J. Wang Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer Gynecol Oncol 69 1998 103 108
10. A. Fagotti, F. Fanfani, and M. Ludovisi Role of laparoscopy to assess the chance of optimal cytoreductive surgery in advanced ovarian cancer: a pilot study Gynecol Oncol 96 2005 729 735
11. A. Fagotti, M.G. Ferrandina, and F. Fanfani A laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma: a pilot study Ann Surg Oncol 13 2006 1156 1161
12. A. Fagotti, G. Ferrandina, and F. Fanfani Prospective validation of a laparoscopic predictive model for optimal cytoreduction in advanced ovarian carcinoma Am J Obstet Gynecol 199 2008 642.e1 642.e6
13. A. Fagotti, G. Vizzielli, and B. Costantini Learning curve and pitfalls of a laparoscopic score to describe peritoneal carcinomatosis in advanced ovarian cancer Acta Obstet Gynecol Scand 90 2011 1126 1131
14. J.L. Brun, R. Rouzier, S. Uzan, and E. Darai External validation of a laparoscopic-based score to evaluate respectability of advanced ovarian cancers: clues for a simplified score Gynecol Oncol 110 2008 354 359
15. R. Simon Optimal two stage design for phase II clinical trials Control Clin Trials 10 1989 1 10
16. J.M. Bland, and D.G. Altman Statistical methods for assessing agreement between two methods of clinical measurement Lancet 1 1986 307 310
17. British Standard Institution Precision of test methods I: guide for the determination and reproducibility for a standard test method (BS 5497, part 1) 1979 British Standard Institution London
18. R.J. Kurman, and IeM. Shih The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory Am J Surg Pathol 34 2010 433 443
19. I. Vergote, C.G. Tropé, and F. Amant European Organization for Research and Treatment of Cancer-Gynaecological Cancer Group; NCIC Clinical Trials Group. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer N Engl J Med 363 2010 943 953
20. F. Heitz, P. Harter, and J. Barinoff Bevacizumab in the treatment of ovarian cancer Adv Ther 29 2012 723 735
21. W.E. Winter 3rd, G.L. Maxwell, and C. Tian Gynecologic Oncology Group. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study J Clin Oncol 26 2008 83 89
22. M.J. Rutten, K.N. Gaarenstroom, and T. Van Gorp Laparoscopy to predict the result of primary cytoreductive surgery in advanced ovarian cancer patients (LapOvCa-trial): a multicentre randomized controlled study BMC Cancer 12 2012 31